Rationale and potential use of cytokines in the prevention and treatment of neonatal sepsis

Clinics in Perinatology

Volumn 25, Issue 3, 1998, Pages 699-710

  Goldman, S ^a   Ellis, R ^a   Dhar, V ^a   Cairo, M S ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; SUPEROXIDE;

CLINICAL TRIAL; HUMAN; INFECTION PREVENTION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NEUTROPHIL; NEWBORN; NEWBORN SEPSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION; VERY LOW BIRTH WEIGHT;

EID: 0031665220     PISSN: 00955108     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0095-5108(18)30106-4     Document Type: Review

References (32)

1. Bedford-Russell A.R. Davies E.G. Gibson F.M. The in vitro effects of granulocyte and granulocyte-macrophage colony-stimulating factor on interleukin 3-dependent proliferation of human neonatal circulating progenitor cells Pediatr Res 37 1995 630
2. Buzby J.S. Lee S.M. DeMaria C.T. Increased granulocyte-macrophage colony-stimulating factor mRNA instability in cord versus adult mononuclear cells is translation-dependent and associated with increased levels of A + U-rich element binding factor Blood 88 1996 2889
3. Cairo M. Granulocyte transfusions in neonates with presumed sepsis Pediatrics 80 1987 738
4. Cairo M. Gillan E. Buzby J. Circulating Steel factor (SLF) and G-CSF levels in preterm and term newborn and adult peripheral blood Am J Pediatr Hematol Oncol 15 1993 311
5. Cairo M. Mauss D. Kommareddy S. Prophylactic or simultaneous administration of recombinant human granulocyte colony stimulating factor in the treatment of group B streptococcal sepsis in neonatal rats Pediatr Res 27 1990 612
6. Cairo M. Mauss D. Plunkett J. Modulation of neonatal myelopoiesis in newborn rats following 7-day administration of either GM-CSF or IL-3 (granulocyte-monocyte colony stimulating factor or interleukin-3) Pediatr Res 29 1991 504
7. Cairo M. Plunkett J. Mauss D. Seven-day administration of recombinant human granulocyte colony-stimulating factor to newborn rats: Modulation of neonatal neutrophilia, myelopoiesis, and group B streptococcus sepsis Blood 76 1990 1788
8. Cairo M. Plunkett J. Nguyen A. Effect of stem cell factor with and without granulocyte colony-stimulating factor on neonatal hematopiesis: In vivo induction of newborn myelopoiesis and reduction of mortality during experimental group B streptococcal sepsis Blood 80 1992 96
9. Cairo M. Plunkett J. Schendel P. The combined effects of Interleukin-11, stem cell factor, and granulocyte colony-stimulating factor on newborn rat hematopoiesis: Significant enhancement of the absolute neutrophil count Exp Hematol 22 1994 1118
10. Cairo M. Seth T. Fanaroff A. A double blinded, randomized, placebo (P) controlled pilot study of rhu GM-CSF (GM) in low birth weight neonates (LBWN). Preliminary results demonstrate a significant reduction in nosocomial infections with rhu GM-CSF Pediatr Res 39 1996 294a [abstract]
11. Cairo M. Suen Y. Knoppel E. Decreased G-CSF and IL-3 production and gene expression from mononuclear cells of newborn infants Pediatr Res 31 1992 574
12. Cairo M. Suen Y. Knoppel E. Decreased stimulated GM-CSF production and GM-CSF gene expression but normal numbers of GM-CSF receptors in human term newborns compared to adults Pediatr Res 30 1991 362
13. Cairo M. van de Ven C. Toy C. Recombinant human granulocyte-macrophage colony-stimulating factor primes neonatal granulocytes for enhanced oxidative metabolism and chemotaxis Pediatr Res 26 1989 395
14. Cairo M.S. Christensen R. Sender L.S. Results of a phase I/II trial of recombinant human granulocyte-macrophage colony-stimulating factor in very low birthweight neonates: Significant induction of circulatory neutrophils, monocytes, platelets and bone marrow neutrophils Blood 86 1995 2509
15. Christensen R. Macfarlane J. Taylor N. Blood and marrow neutrophils during experimental group B streptococcal infection: Quantification of the stem cell, proliferative, storage and circulating pools Pediatr Res 16 1982 549
16. English K. Hammond W. Lewis D. Decreased granulocyte-macrophage colony stimulating factor production by human neonatal blood mononuclear cells and T cells Pediatr Res 31 1992 211
17. Fanaroff A. Korones S. Wright L. A controlled trial of intravenous immune globulin to reduce nosocomial infections in very-low-birth-weight infants N Engl J Med 330 1994 1107
18. Gessler P. Kirchmann N. Kientsch-Engel R. Serum concentrations of granulocyte colony-stimulating factor in healthy term and preterm neonates and in those with various diseases including bacterial infections Blood 82 1993 3177
19. Gillan E. Christensen R. Suen Y. A randomized, placebo-controlled trial of recombinant human granulocyte-colony stimulating factor administration in newborn infants with presumed sepsis: Significant induction of peripheral and bone marrow neutrophilia Blood 84 1994 1427
20. Ikeno K. Increased granulocyte-colony stimulating factor (G-CSF) levels in neonates with perinatal complications Acta Paediatr Jpn 36 1994 366
21. Jaswon M.S. Jones H.M. Linch D.C. The effects of recombinant human granulocyte-macrophage colony stimulating factor on the neutrophil respiratory burst in the term and preterm infant when studied in whole blood Pediatr Res 36 1994 623
22. Metcalf D. Metcalf N. Nicos A. The hematopoietic colony-stimulating factors: From biology to clinical applications Cambridge U Pr 69.95 1995 352
23. Nankervis C. Sequin J. Granulocyte colony-stimulating factor for neutropenia in neonatal sepsis Arch Pediatr Adolesc Med 149 1995 218
24. Polin R. St Gerne J. Neonatal sepsis Adv Pediatr Infect Dis 7 1992 25
25. Rosenthal H. Healey T. Ellis R. A two year follow-up of neonates with presumed sepsis treated with recombinant human granulocyte colony-stimulating factor during the first week of life J Pediatr 128 1996 135
26. Russell A.R. Davies E.G. Ball S.E. Granulocyte colony stimulating factor treatment for neonatal neutropenia Arch Dis Child 72 1995 F53
27. Schibier K. Liechty K. White W. Production of granulocyte colony-stimulating factor in vitro by monocytes from preterm and term neonates Blood 82 1993 2478
28. Shaw G. Kamen R. A conserved AU sequence from the 3’ untranslated region of GM-CSF mRNA mediates selective mRNA degradation Cell 46 1986 659
29. Siegel J. McCracken G. Sepsis neonatorum N Engl J Med 304 1981 642
30. Stoll B.J. Gordon T. Korones S.B. Early-onset sepsis in very low birth weight neonates: A report from the National Institute of Child Health and Human Development Neonatal Research Network J Pediatr 129 1996 72
31. Stoll B.J. Gordon T. Korones S.B. Late-onset sepsis in very low birth weight neonates: A report from the National Institute of Child Health and Human Development Neonatal Research Network J Pediatr 129 1996 63
32. Wheeler J.G. Givner L.B. Therapeutic use of recombinant human granulocyte-macro-phage colony-stimulating factor in neonatal rats with type III group B streptococcal sepsis J Infect Dis 165 1992 938